Mayo clinic grows Cancer-Killing cells from Patient's own blood in early trial
NCT ID NCT05411497
Summary
This early-stage trial is testing whether a patient's own immune cells can be grown in a lab to fight multiple myeloma that has returned or stopped responding to other treatments. Doctors take T-cells from the patient's blood, grow them to target a specific protein found on cancer cells (MUC1), and then infuse them back into the patient. The main goal is to find a safe dose and understand side effects in a small group of 5 patients with advanced disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT PLASMA CELL MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic Hospital in Arizona
Phoenix, Arizona, 85054, United States
-
Mayo Clinic in Arizona
Scottsdale, Arizona, 85259, United States
Conditions
Explore the condition pages connected to this study.